Literature DB >> 9114956

Risperidone, weight gain, and bulimia nervosa.

D N Crockford, G Fisher, P Barker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9114956     DOI： 10.1177/070674379704200327

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  3 in total

1.  Clozapine/olanzapine-induced recurrence or deterioration of binge eating-related eating disorders.

Authors:  S Gebhardt; M Haberhausen; J-C Krieg; H Remschmidt; M Heinzel-Gutenbrunner; J Hebebrand; F M Theisen
Journal:  J Neural Transm (Vienna)       Date:  2007-03-20       Impact factor: 3.575

Review 2.  Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa.

Authors:  Susan L McElroy; Anna I Guerdjikova; Nicole Mori; Francisco Romo-Nava
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

3.  Psychotropic drug prescribing in an Australian specialist child and adolescent eating disorder service: a retrospective study.

Authors:  Julia K Moore; Hunna J Watson; Emily Harper; Julie McCormack; Thinh Nguyen
Journal:  J Eat Disord       Date:  2013-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.